Classifying necrotising mpox as an AIDS-defining condition
Lancet
.
2023 Nov 11;402(10414):1751-1752.
doi: 10.1016/S0140-6736(23)01896-2.
Authors
Oriol Mitjà
1
,
Roger Paredes
2
,
Brenda Cabtree
3
,
Chloe Orkin
4
Affiliations
1
Skin, Neglected Tropical Diseases, and Sexually Transmitted Infections Section, Fight Infectious Diseases Foundation, University Hospital Germans Trias i Pujol, Badalona 08916, Spain. Electronic address: omitja@lluita.org.
2
Departamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición, Salvador Zubirán, Mexico City, Mexico.
3
Infectious Disease Department, Fight Infectious Diseases Foundation, University Hospital Germans Trias i Pujol, Badalona 08916, Spain.
4
Blizard Institute and SHARE Collaborative, Department of Infection and Immunity, Queen Mary University of London, London, UK.
PMID:
37951688
DOI:
10.1016/S0140-6736(23)01896-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Acquired Immunodeficiency Syndrome*
Humans
Mpox (monkeypox)*